Zenas BioPharma reports positive phase 3 trial results for obexelimab

Markets Investing.com By Investing.com 02 Jun 2026 23:13 1 min read

Zenas BioPharma reports positive phase 3 trial results for obexelimab

Zenas BioPharma reports positive phase 3 trial results for obexelimab

Zenas BioPharma reports positive phase 3 trial results for obexelimab

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.